Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|August 28, 1999
Familial sarcoidosis in Finland and Hokkaido, Japan--a comparative studyA Pietinalho, M Ohmichi, M Hirasawa, et al.
Sarcoidosis|March 1, 1995
The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological studyA Pietinalho, Y Hiraga, Y Hosoda, et al.
Respiratory Medicine|June 9, 1998
Beta 2-agonists administered by a dry powder inhaler can be used in acute asthmaA Nana, P Youngchaiyud, N Maranetra, et al.
The European Respiratory Journal|February 4, 2006
Formoterol Turbuhaler as reliever medication in patients with acute asthmaA R Rubinfeld, R Scicchitano, A Hunt, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 22, 1998
High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attackA Nana, P Youngchaiyud, S Charoenratanakul, et al.
Respiratory Medicine|March 26, 2011
Comparing asthma treatment in elderly versus younger patientsJ Haughney, M Aubier, L Jørgensen, et al.
Respiratory Medicine|September 26, 2003
Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthmaW Boonsawat, S Charoenratanakul, C Pothirat, et al.
Biopharmaceutics & Drug Disposition|July 1, 1993
Relationship between lung tissue and blood plasma concentrations of inhaled budesonideJ M Van den Bosch, C J Westermann, J Aumann, et al.
Allergy|December 1, 1994
Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patientsO Selroos, R Backman, K O Forsén, et al.
The European Respiratory Journal|July 3, 2010
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapyM Aubier, R Buhl, T Ekström, et al.
Pageof 8